StockData
Axsome Therapeutics, Inc. logo

Axsome Therapeutics, Inc. (AXSM) stock

AXSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 8/30
$134.00−1.95 (-1.43%)

Close on Nov 18, 2026Market cap $7.02BP/E –Yield –

Axsome Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Axsome Therapeutics's EV/EBITDA was 4.0× on Jul 31, 2018, against 2.6× a year earlier.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2018Jul 31, 20184.0×+0.1
2017Dec 29, 20173.9×−0.2
2016Dec 30, 20164.1×–

More Axsome Therapeutics figures

See a number that looks wrong?